Hope for vascular cognitive impairment: Ac-YVAD-cmk as a novel treatment against white matter rarefaction.

BCAS induced a reduction in occludin that almost reached significance ( Fig 5D ) that became significantly elevated in the Ac-YVAD-cmk treated group when compared to the vehicle treated group ( Fig 5D ).

also in 65 other papers